Sobi shows strong growth despite haemophilia competition - PMLiVE
Sobi shows strong growth despite haemophilia competition PMLiVE
Rare disease specialist Swedish Orphan Biovitrum (Sobi) has posted strong growth for the first quarter of the year, led by its haemophilia franchise.
Comments
Post a Comment